Raman Singh
Director/Board Member chez LIQUIDIA CORPORATION
Fortune : - $ au 31/03/2024
Profil
Raman Singh is currently the Chief Executive Officer at Juniper Biologics Pte Ltd., and an Independent Director at both Liquidia Technologies, Inc. and Liquidia Corp.
Prior to his current roles, he served as the Chief Executive Officer at Mundipharma Pte Ltd.
from 2011 to 2020.
He also held various regional and general management positions at Abbott Laboratories NZ Ltd., Abbott Australia Pty Ltd., and Abbott Korea Ltd.
from 2005 to 2008.
From 2008 to 2011, he was the Vice President-Commercial Operations at GSK Plc.
Mr. Singh holds a graduate degree from Thunderbird School of Global Management, an undergraduate degree from Osmania University, and an MBA from Assumption University.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
LIQUIDIA CORPORATION
-.--% | 19/06/2023 | 0 ( -.--% ) | - $ | 31/03/2024 |
Postes actifs de Raman Singh
| Sociétés | Poste | Début |
|---|---|---|
| LIQUIDIA CORPORATION | Director/Board Member | 28/06/2020 |
Liquidia Technologies, Inc.
 Liquidia Technologies, Inc. Pharmaceuticals: MajorHealth Technology Liquidia Technologies, Inc. is a clinical biopharmaceutical company focused on the development and commercialization of human therapeutics using its proprietary PRINT technology to transform the lives of patients. It operates in two segments: Pharmaceutical Products and Partnering & Licensing. The two product candidates from its pipeline: LIQ861 for the treatment of pulmonary arterial hypertension and LIQ865 for the treatment of local post-operative pain. Liquidia Technologies was founded by Joseph M. DeSimone, Ashok K. Mendiratta, Edward T. Samulski, William R. Kenan, Ginger Denison and Jason Rolland in 2004 and is headquartered in Morrisville, NC. | Director/Board Member | 01/12/2020 |
Juniper Biologics Pte Ltd.
 Juniper Biologics Pte Ltd. Miscellaneous Commercial ServicesCommercial Services Juniper Biologics Pte Ltd is a science-led pharmaceutical company based in Singapore, Singapore. Juniper Biologics is backed by the Sylvan Group and is focused on delivering novel therapies to improve the health and quality of life of patients. The Singaporean company has a growing presence in oncology and oncology supportive care, rare/orphan diseases, and gene therapy. The company was founded with a vision to provide treatments for unmet medical needs in specialist therapy areas. Raman Singh has been the CEO of the company since 2020. | Chief Executive Officer | 01/12/2020 |
Anciens postes connus de Raman Singh
| Sociétés | Poste | Fin |
|---|---|---|
Mundipharma Pte Ltd.
 Mundipharma Pte Ltd. Pharmaceuticals: MajorHealth Technology Mundipharma Pte Ltd. develops pharmaceutical products. Its therapy area includes analgesia, oncology, ophthalmology, respiratory, specialty care, and consumer healthcare. The company was founded in 2004 and is headquartered in Singapore. | Chief Executive Officer | 01/12/2020 |
| GSK PLC | Corporate Officer/Principal | 01/01/2011 |
| Abbott Australia Pty Ltd. | Corporate Officer/Principal | 01/01/2008 |
| Abbott Laboratories NZ Ltd. | Corporate Officer/Principal | 01/01/2008 |
Abbott Korea Ltd.
 Abbott Korea Ltd. Medical DistributorsDistribution Services Abbott Korea Ltd. engages in the distribution of medical equipment, reagents, medicines, nutritional products, infant formula and baby foods. The company was founded on May 24, 1988 and is headquartered in Seoul, South Korea. | Corporate Officer/Principal | 01/01/2007 |
Formation de Raman Singh
| Thunderbird School of Global Management | Graduate Degree |
| Osmania University | Undergraduate Degree |
| Assumption University | Masters Business Admin |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 2 |
|---|---|
| GSK PLC | Health Technology |
| LIQUIDIA CORPORATION | Health Technology |
| Entreprise privées | 6 |
|---|---|
Liquidia Technologies, Inc.
Liquidia Technologies, Inc. Pharmaceuticals: MajorHealth Technology Liquidia Technologies, Inc. is a clinical biopharmaceutical company focused on the development and commercialization of human therapeutics using its proprietary PRINT technology to transform the lives of patients. It operates in two segments: Pharmaceutical Products and Partnering & Licensing. The two product candidates from its pipeline: LIQ861 for the treatment of pulmonary arterial hypertension and LIQ865 for the treatment of local post-operative pain. Liquidia Technologies was founded by Joseph M. DeSimone, Ashok K. Mendiratta, Edward T. Samulski, William R. Kenan, Ginger Denison and Jason Rolland in 2004 and is headquartered in Morrisville, NC. | Health Technology |
Abbott Korea Ltd.
Abbott Korea Ltd. Medical DistributorsDistribution Services Abbott Korea Ltd. engages in the distribution of medical equipment, reagents, medicines, nutritional products, infant formula and baby foods. The company was founded on May 24, 1988 and is headquartered in Seoul, South Korea. | Distribution Services |
| Abbott Laboratories NZ Ltd. | |
Mundipharma Pte Ltd.
Mundipharma Pte Ltd. Pharmaceuticals: MajorHealth Technology Mundipharma Pte Ltd. develops pharmaceutical products. Its therapy area includes analgesia, oncology, ophthalmology, respiratory, specialty care, and consumer healthcare. The company was founded in 2004 and is headquartered in Singapore. | Health Technology |
| Abbott Australia Pty Ltd. | |
Juniper Biologics Pte Ltd.
Juniper Biologics Pte Ltd. Miscellaneous Commercial ServicesCommercial Services Juniper Biologics Pte Ltd is a science-led pharmaceutical company based in Singapore, Singapore. Juniper Biologics is backed by the Sylvan Group and is focused on delivering novel therapies to improve the health and quality of life of patients. The Singaporean company has a growing presence in oncology and oncology supportive care, rare/orphan diseases, and gene therapy. The company was founded with a vision to provide treatments for unmet medical needs in specialist therapy areas. Raman Singh has been the CEO of the company since 2020. | Commercial Services |
